OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
9.20
-0.79 (-7.91%)
At close: May 12, 2025, 4:00 PM
11.49
+2.29 (24.89%)
After-hours: May 12, 2025, 7:57 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $170.14 million as of May 12, 2025. Its market cap has increased by 2.12% in one year.
Market Cap
170.14M
Enterprise Value
186.37M
1-Year Change
2.12%
Ranking
Category
Stock Price
$9.20
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $170.14M, an increase of 397.48%. That is a compound annual growth rate of 26.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 184.70M | 106.37% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.87B |
| Johnson & Johnson | 370.90B |
| UnitedHealth Group | 343.41B |
| AbbVie | 335.67B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.47B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |